1. Exploring the mechanism of tryptophan 2,3-dioxygenase
- Author
-
Stephen K Chapman, Sarah J. Thackray, and Christopher G. Mowat
- Subjects
inorganic chemicals ,Kynurenine pathway ,indoleamine 2,3-dioxygenase ,Stereochemistry ,hIDO, Homo sapiens IDO ,tryptophan 2,3-dioxygenase ,Redox ,Biochemistry ,TDO, tryptophan 2,3-dioxygenase ,Catalysis ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Catalytic Domain ,Animals ,Humans ,Indoleamine-Pyrrole 2,3,-Dioxygenase ,xcTDO, Xanthomonas campestris TDO ,Indoleamine 2,3-dioxygenase ,rmTDO, Ralstonia metallidurans TDO ,030304 developmental biology ,chemistry.chemical_classification ,0303 health sciences ,Catabolism ,Tryptophan ,haem ,Tryptophan Oxygenase ,3. Good health ,kynurenine ,IDO, indoleamine 2,3-dioxygenase ,Enzyme ,chemistry ,030220 oncology & carcinogenesis ,Biochemical Society Focused Meetings ,oxygen ,Function (biology) ,Kynurenine - Abstract
The haem proteins TDO (tryptophan 2,3-dioxygenase) and IDO (indoleamine 2,3-dioxygenase) are specific and powerful oxidation catalysts that insert one molecule of dioxygen into L-tryptophan in the first and rate-limiting step in the kynurenine pathway. Recent crystallographic and biochemical analyses of TDO and IDO have greatly aided our understanding of the mechanisms employed by these enzymes in the binding and activation of dioxygen and tryptophan. In the present paper, we briefly discuss the function, structure and possible catalytic mechanism of these enzymes.
- Published
- 2008
- Full Text
- View/download PDF